Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif containing 11 (TRIM11) is a protein characterized by a RING domain, two B-box domains, and a coiled-coil region, consistent with TRIM family structure[1][3][6]. It acts mainly as an E3 ubiquitin ligase regulating clearance of misfolded or aggregated proteins via the ubiquitin-proteasome system (UPS), as well as protein quality control mechanisms in the cytoplasm and nucleus[2][3][4][5]. TRIM11 also modulates SUMOylation and the degradation of key regulatory proteins such as olfactory neurogenic transcription factor PAX6. It has prominent roles in neurogenesis, cancer cell proliferation, protein aggregation diseases, and the innate immune response[2][3][5][7]. Abnormal TRIM11 expression is associated with oncogenesis and neurodegenerative disorders, positioning it as a therapeutic interest in these diseases. TRIM11 does not have any currently approved drugs targeting its activity, but its role in fundamental cellular processes and disease makes it a focus for ongoing research interventions.
Promotion of misfolded protein degradation via the ubiquitin-proteasome system (UPS); Inhibition of pathogenic protein aggregation and proteostasis restoration; Suppression of viral gene expression (antiviral function); Regulation of transcription factor degradation (e.g., PAX6); SUMOylation-dependent protein removal; Autophagy-dependent degradation of AIM2 inflammasome
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif containing 11 (TRIM11).